Core A: Administrative Core
Core A: Administrative Core
批准号:
10203851
负责人:
Roy S Herbst
金额:
$15.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-26 至 2025-07-31
关键词:
AchievementAdvocacyAdvocateBasic ScienceCancer BiologyClinicalClinical ResearchCollaborationsCommunicationConflict (Psychology)ConsultationsDataDevelopmentDisputesEnsureEvaluationFoundationsFundingFutureGoalsGovernmentGrantHuman ResourcesHuman Subject ResearchInfrastructureInstitutionLaboratory FindingLeadershipMalignant neoplasm of lungMonitorNational Cancer InstituteOccupational activity of managing financesPatientsPhilanthropic FundPreparationPrincipal InvestigatorPrivatizationProgram EvaluationProgress ReportsPublicationsRegulationResearchResearch PersonnelResearch PriorityResourcesSeriesSourceTimeTimeLineTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesYale Cancer Centeranticancer researchcareercost effectivemeetingsneoplasm resourcenoveloperationoutreachpersonalized medicineprogramssuccesssymposiumtranslational cancer researchwebsite development
中文摘要
核心摘要
行政核心(核心 A)由耶鲁大学 SPORE 肺科首席研究员 Roy Herbst 指导
癌症 (YSILC),由 Ed Kaftan 联合指导,并得到项目财务管理团队的支持。
行政核心的认真监督对于确保耶鲁 SPORE 在肺部的成功至关重要
癌症。 Core A 是 YCC 研究管理部门提供的现有基础设施的扩展,用于支持
并促进跨学科研究工作。行政核心作为中央协调
所有 YSILC 调查员的重点,负责监控所有项目和核心的进展,以实现
转化/临床终点。核心董事和联合董事以及YISLC Co-PI(陈博士)
负责领导 YSILC 项目、设定转化研究优先事项、确定新的
来自新兴数据的转化研究机会,监测所有项目、核心和
开发项目并确定项目、核心和转化研究方向的变化
需要。核心 A 促进了 YSILC 研究人员之间的互动,以加速研究的转化
实验室研究结果纳入拟议的和未来的临床研究。如果需要,核心 A 总监将负责管理
YSILC 调查员之间的冲突。作为一个团队,核心人员监控财务、维护
项目和核心领导人之间的沟通和协调会议,包括每周的肺癌会议
翻译小组研讨会系列、执行委员会月度会议、翻译小组年会
内部/外部顾问委员会以及年度 YSILC SEP 和 DRP 研讨会。除了这些
功能,核心是与 NCI、其他肺癌 SPORE、耶鲁癌症中心和
耶鲁大学,并协调外展工作,包括出版物(内部和外部)、网站
开发、研讨会、患者/研究宣传活动和筹款计划。通过这些
管理活动,核心 A 对于 YSILC 计划的组织、开发
耶鲁大学肺癌基础/临床/转化研究的广泛文化和高效成果
既定的计划目标,最终目标是对肺病患者产生重大临床影响
癌症。
英文摘要
CORE SUMMARY
The Administrative Core (Core A) is directed by Roy Herbst, Principal Investigator of the Yale SPORE in Lung
Cancer (YSILC), and co-directed by Ed Kaftan, with support from the program financial management team.
Careful oversight by the Administrative Core will be critical to ensure the success of the Yale SPORE in Lung
Cancer. Core A is an extension of existing infrastructure provided by YCC Research Administration to support
and facilitate transdisciplinary research efforts. The Administrative Core serves as the central coordination
point for all YSILC investigators, with responsibility for monitoring the progress of all projects and cores toward
a translational/clinical endpoint. The Core Director and Co-Director along with the YISLC Co-PI (Dr. Chen)
have responsibility for leading the YSILC program, setting translational research priorities, identifying new
translational research opportunities from emerging data, monitoring the progress of all projects, cores and
developmental projects and determining changes in direction of projects, cores and translational research as
needed. Interactions among YSILC investigators is facilitated by Core A to accelerate the translation of
laboratory findings into the proposed and future clinical studies. If required, the Core A Director will manage
conflicts among YSILC investigators. As a team, the Core personnel monitors finances, maintains
communications among project and core leaders and coordinates meetings, including the weekly lung cancer
translational group seminar series, monthly meetings of the Executive Committee, annual meetings of the
Internal/External Advisory boards and the annual YSILC SEP and DRP Symposium. In addition to these
functions, the Core is the primary interface with the NCI, other lung cancer SPOREs, Yale Cancer Center and
Yale University, and coordinates outreach efforts, including publications (internal and external), website
development, seminars, patient/research advocacy activities, and fundraising programs. Through these
administrative activities, Core A is essential to the organization of the YSILC program, to developing a
widespread culture of lung cancer basic/clinical/translational research at Yale and to the efficient achievement
of the stated program objectives, with the ultimate goal of a significant clinical impact for patients with lung
cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yale Cancer Center NCTN LAPS
-
批准号:10359158
-
项目类别:
-
资助金额:$48.49万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10582614
-
项目类别:
-
资助金额:$87.91万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale Cancer Center NCTN LAPS
-
批准号:10734497
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2019
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:10203850
-
项目类别:
-
资助金额:$200.37万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer Developmental Research Program
-
批准号:10203857
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9767058
-
项目类别:
-
资助金额:$213.48万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:9338869
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
-
批准号:8931829
-
项目类别:
-
资助金额:$218.5万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma
-
批准号:9379210
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Administrative Core
-
批准号:8931832
-
项目类别:
-
资助金额:$86.07万
-
财政年份:2015
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8920514
-
项目类别:
-
资助金额:$55.45万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8707401
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8517039
-
项目类别:
-
资助金额:$52.79万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8332772
-
项目类别:
-
资助金额:$56.49万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways
-
批准号:8186504
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2011
-
负责人:Roy S Herbst
-
依托单位:
U10 Ful Member Application Affiliated with SWOG
-
批准号:7555078
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
U10 Full Member Application Affiliated with SWOG
-
批准号:7767468
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2004
-
负责人:Roy S Herbst
-
依托单位:
Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors
-
批准号:6563965
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6563968
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2002
-
负责人:Roy S Herbst
-
依托单位:
Core--Clinical trials
-
批准号:6499818
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2001
-
负责人:Roy S Herbst
-
依托单位:
海外基金